Bessemer Group Inc. Sells 3,846 Shares of DaVita Inc. $DVA

Bessemer Group Inc. cut its position in shares of DaVita Inc. (NYSE:DVA) by 54.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,171 shares of the company’s stock after selling 3,846 shares during the period. Bessemer Group Inc.’s holdings in DaVita were worth $451,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DVA. Concurrent Investment Advisors LLC purchased a new stake in DaVita during the first quarter valued at approximately $223,000. Envestnet Asset Management Inc. raised its position in DaVita by 7.9% during the first quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company’s stock valued at $8,452,000 after purchasing an additional 4,048 shares during the period. OneDigital Investment Advisors LLC purchased a new stake in DaVita during the first quarter valued at approximately $200,000. Teacher Retirement System of Texas purchased a new stake in DaVita during the first quarter valued at approximately $1,010,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in DaVita during the first quarter valued at approximately $364,000. 90.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DVA. Truist Financial set a $140.00 price objective on DaVita in a research report on Tuesday, October 14th. Wall Street Zen downgraded DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Barclays reduced their price target on DaVita from $149.00 to $143.00 and set an “equal weight” rating on the stock in a report on Thursday. Bank of America reduced their price target on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a report on Wednesday, September 10th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of DaVita in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $151.75.

DaVita Stock Up 0.1%

DVA opened at $118.84 on Monday. The stock’s fifty day moving average is $130.78 and its two-hundred day moving average is $136.56. The company has a market capitalization of $8.50 billion, a P/E ratio of 12.24, a PEG ratio of 0.91 and a beta of 1.13. DaVita Inc. has a 52 week low of $115.39 and a 52 week high of $179.60.

DaVita (NYSE:DVA) last released its quarterly earnings data on Wednesday, October 29th. The company reported $2.51 EPS for the quarter, missing the consensus estimate of $3.17 by ($0.66). The firm had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.43 billion. DaVita had a return on equity of 815.62% and a net margin of 5.80%.The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.59 earnings per share. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. Equities analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.